Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v1-EN
Language English English
Date Updated 2019-09-13 2018-01-02
Drug Identification Number 02145820 02145820
Brand name ADENOCARD INJECTION -PRE-FILLED SYRINGE ADENOCARD INJECTION -PRE-FILLED SYRINGE
Common or Proper name Adenosine Injection USP Adenosine Injection USP
Company Name ASTELLAS PHARMA CANADA INC ASTELLAS PHARMA CANADA INC
Ingredients ADENOSINE ADENOSINE
Strength(s) 3MG 3MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 6 mg/2mL and 12 mg/4mL pre-filled syringes 6 mg/2mL and 12 mg/4mL pre-filled syringes
ATC code C01EB C01EB
ATC description OTHER CARDIAC PREPARATIONS OTHER CARDIAC PREPARATIONS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-01-31 2018-07-03
Actual discontinuation date 2019-08-30
Remaining supply date 2019-08-30 2018-07-03
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments The discontinuation is part of the lifecycle management of the product. The discontinuation is part of the lifecycle management of the product.
Health Canada comments